{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:02:44Z","timestamp":1778648564015,"version":"3.51.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":1739,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031829","name":"Ceva Sant\u00e9 Animale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diuretic braking during furosemide continuous rate infusion (FCRI) curtails urine production.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Renin-angiotensin-aldosterone system (RAAS) activation mediates braking, and RAAS inhibition will increase urine production.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Ten healthy purpose-bred male dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Dogs received placebo, benazepril, or benazepril and spironolactone PO for 3\u2009days before a 5-hour FCRI (0.66\u2009mg\/kg\/h) in a 3-way, randomized, blinded, cross-over design. Body weight (BW), serum creatinine concentration (sCr), serum electrolyte concentrations, PCV, and total protein concentration were measured before PO medications, at hours\u20090 and 5 of FCRI, and at hour\u200924. During the FCRI, water intake, urine output, urine creatinine concentration, and urine electrolyte concentrations were measured hourly. Selected RAAS components were measured before and after FCRI. Variables were compared among time points and treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Diuretic braking and urine production were not different among treatments. Loss of BW, hemoconcentration, and decreased serum chloride concentration occurred during FCRI with incomplete recovery at hour\u200924 for all treatments. Although unchanged during FCRI, sCr increased and serum sodium concentration decreased at hour\u200924 for all treatments. Plasma aldosterone and angiotensin-II concentrations increased significantly at hour\u20095 for all treatments, despite suppressed angiotensin-converting enzyme activity during benazepril background treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The neurohormonal profile during FCRI supports RAAS mediation of diuretic braking in this model. Background treatment with benazepril with or without spironolactone did not mitigate braking, but was well\u2009tolerated. Delayed changes in sCr and serum sodium concentration and incomplete recovery of hydration indicators caused by furosemide hold implications for clinical patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.16097","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T13:36:41Z","timestamp":1615642601000},"page":"1245-1254","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0972-0365","authenticated-orcid":false,"given":"Darcy","family":"Adin","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, University of Florida , Gainesville, Florida,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-4625","authenticated-orcid":false,"given":"Clarke","family":"Atkins","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, North Carolina,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Wallace","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Illinois , Urbana, Illinois,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Klein","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, North Carolina,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"2026020303064201100_jvim16097-bib-0001","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1939-1676.2003.tb02493.x","article-title":"Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs","volume":"17","author":"Adin","year":"2003","journal-title":"J Vet Intern Med"},{"key":"2026020303064201100_jvim16097-bib-0002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jvc.2016.09.004","article-title":"Furosemide continuous rate infusion diluted with 5% dextrose in water or hypertonic saline in normal adult dogs: a pilot study","volume":"19","author":"Adin","year":"2016","journal-title":"J Vet Cardiol"},{"key":"2026020303064201100_jvim16097-bib-0003","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1939-1676.2003.tb02529.x","article-title":"Furosemide continuous rate infusion in the horse: evaluation of enhanced efficacy and reduced side effects","volume":"17","author":"Johansson","year":"2003","journal-title":"J Vet Intern Med"},{"key":"2026020303064201100_jvim16097-bib-0004","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jvc.2018.01.003","article-title":"Pharmacodynamic assessment of diuretic efficacy and braking in a furosemide continuous infusion model","volume":"20","author":"Adin","year":"2018","journal-title":"J Vet Cardiol"},{"key":"2026020303064201100_jvim16097-bib-0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020303064201100_jvim16097-bib-0006","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2026020303064201100_jvim16097-bib-0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026020303064201100_jvim16097-bib-0008","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026020303064201100_jvim16097-bib-0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jvc.2019.12.002","article-title":"DELay of Appearance of sYmptoms of canine degenerative mitral valve disease treated with spironolactone and benazepril: the DELAY study","volume":"27","author":"Borgarelli","year":"2020","journal-title":"J Vet Cardiol"},{"key":"2026020303064201100_jvim16097-bib-0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1939-1676.2009.0467.x","article-title":"Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease","volume":"24","author":"Bernay","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020303064201100_jvim16097-bib-0011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1760-2734(06)70025-X","article-title":"The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial","volume":"1","author":"BENCH (BENazepril in Canine Heart disease) Study Group","year":"1999","journal-title":"J Vet Cardiol"},{"key":"2026020303064201100_jvim16097-bib-0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1939-1676.1995.tb01075.x","article-title":"Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group","volume":"9","author":"The COVE Study Group","year":"1995","journal-title":"J Vet Intern Med"},{"key":"2026020303064201100_jvim16097-bib-0013","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/jvim.12141","article-title":"Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study","volume":"27","author":"Lefebvre","year":"2013","journal-title":"J Vet Intern Med"},{"key":"2026020303064201100_jvim16097-bib-0014","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2460\/ajvr.1995.56.12.1620","article-title":"Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs","volume":"56","author":"King","year":"1995","journal-title":"Am J Vet Res"},{"key":"2026020303064201100_jvim16097-bib-0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/jvp.12475","article-title":"Effect of benazepril and pimobendan on serum angiotensin-converting enzyme activity in dogs","volume":"41","author":"King","year":"2018","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303064201100_jvim16097-bib-0016","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s11095-014-1587-9","article-title":"Pharmacokinetic\/pharmacodynamic modeling of renin-angiotensin aldosterone biomarkers following angiotensin-converting enzyme (ACE) inhibition therapy with benazepril in dogs","volume":"32","author":"Mochel","year":"2015","journal-title":"Pharm Res"},{"key":"2026020303064201100_jvim16097-bib-0017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2885.2009.01130.x","article-title":"A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog","volume":"33","author":"Guyonnet","year":"2010","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303064201100_jvim16097-bib-0018","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/07420528.2014.897711","article-title":"Influence of feeding schedules on the chronobiology of renin activity, urinary electrolytes and blood pressure in dogs","volume":"31","author":"Mochel","year":"2014","journal-title":"Chronobiol Int"},{"key":"2026020303064201100_jvim16097-bib-0019","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jvp.12216","article-title":"The effect of enalapril on furosemide-activated renin \u2013 angiotensin \u2013 aldosterone system in healthy dogs","volume":"38","author":"Lantis","year":"2015","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303064201100_jvim16097-bib-0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jvc.2017.03.001","article-title":"Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease","volume":"19","author":"Ames","year":"2017","journal-title":"J Vet Cardiol"},{"issue":"3","key":"2026020303064201100_jvim16097-bib-0021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/FPC.0000000000000322","article-title":"Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease","volume":"28","author":"Meurs","year":"2018","journal-title":"Pharmacogenet Genomics"},{"key":"2026020303064201100_jvim16097-bib-0022","doi-asserted-by":"crossref","DOI":"10.1177\/1470320317737184","article-title":"Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism","volume":"18","author":"Meurs","year":"2017","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020303064201100_jvim16097-bib-0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320316633897","article-title":"Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition","volume":"17","author":"Ames","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020303064201100_jvim16097-bib-0024","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jvp.12011","article-title":"Utility of urinary aldosterone measurement in quantitating RAAS activation","volume":"35","author":"Atkins","year":"2012","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020303064201100_jvim16097-bib-0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-180","article-title":"The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism","volume":"9","author":"Eudy","year":"2011","journal-title":"J Transl Med"},{"issue":"3","key":"2026020303064201100_jvim16097-bib-0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12245-017-0143-x","article-title":"Markers of diuretic resistance in emergency department patients with acute heart failure","volume":"10","author":"Doering","year":"2017","journal-title":"Int J Emerg Med"},{"key":"2026020303064201100_jvim16097-bib-0027","first-page":"379","article-title":"Editor's Choice-Diuretic resistance in acute heart failure","volume":"7","author":"Verbrugge","year":"2018","journal-title":"Eur Hear J Acute Cardiovasc Care"},{"key":"2026020303064201100_jvim16097-bib-0028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jvim.15662","article-title":"Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease","volume":"34","author":"Adin","year":"2020","journal-title":"J Vet Intern Med"},{"key":"2026020303064201100_jvim16097-bib-0029","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/vec.12301","article-title":"Comparison of the diuretic effect of furosemide by different methods of administration in healthy dogs","volume":"25","author":"Harada","year":"2015","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020303064201100_jvim16097-bib-0030","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.2174\/1381612811319170012","article-title":"Non-ACE pathway-induced angiotensin II production","volume":"19","author":"Uehara","year":"2013","journal-title":"Curr Pharm Des"},{"key":"2026020303064201100_jvim16097-bib-0031","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1357-2725(02)00178-4","article-title":"Local renin\u2013angiotensin systems: the unanswered questions","volume":"35","author":"Danser","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"2026020303064201100_jvim16097-bib-0032","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0022-3565(24)35393-5","article-title":"Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic\/pharmacodynamic modeling approach","volume":"292","author":"Toutain","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"2026020303064201100_jvim16097-bib-0033","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14105","article-title":"Both aldosterone and spironolactone can modulate the intracellular ACE\/ANG II\/AT1 and ACE2\/ANG (1-7)\/MAS receptor axes in human mesangial cells","volume":"7","author":"Stoll","year":"2019","journal-title":"Physiol Rep"},{"key":"2026020303064201100_jvim16097-bib-0034","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2460\/ajvr.68.10.1045","article-title":"Modulation of the tissue renin-angiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve","volume":"68","author":"Fujii","year":"2007","journal-title":"Am J Vet Res"},{"key":"2026020303064201100_jvim16097-bib-0035","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2460\/ajvr.69.12.1574","article-title":"Comparison of the effects of candesartan cilexetil and enalapril maleate on right ventricular myocardial remodeling in dogs with experimentally induced pulmonary stenosis","volume":"69","author":"Yamane","year":"2008","journal-title":"Am J Vet Res"},{"key":"2026020303064201100_jvim16097-bib-0036","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.vh.2018.10.001","article-title":"Paracrine regulation of aldosterone secretion in physiological and pathophysiological conditions","volume":"109","author":"Lefebvre","year":"2019","journal-title":"Vitam Horm"},{"key":"2026020303064201100_jvim16097-bib-0037","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.2460\/ajvr.1993.54.10.1758","article-title":"Influence of hydration state on renal function of dogs","volume":"54","author":"Tabaru","year":"1993","journal-title":"Am J Vet Res"},{"key":"2026020303064201100_jvim16097-bib-0038","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/jvim.14524","article-title":"Preliminary investigation of cardiovascular-renal disorders in dogs with chronic mitral valve disease","volume":"30","author":"Martinelli","year":"2016","journal-title":"J Vet Intern Med"},{"key":"2026020303064201100_jvim16097-bib-0039","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jsap.12387","article-title":"Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement","volume":"56","author":"Pouchelon","year":"2015","journal-title":"J Small Anim Pract"},{"key":"2026020303064201100_jvim16097-bib-0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1292\/jvms.65.1057","article-title":"The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats","volume":"65","author":"Uechi","year":"2003","journal-title":"J Vet Med Sci"},{"key":"2026020303064201100_jvim16097-bib-0041","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0090-4295(90)80148-G","article-title":"Furosemide-induced disturbances of renal function in patients undergoing TURP","volume":"35","author":"Donatucci","year":"1990","journal-title":"Urology"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.16097","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.16097","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/35\/3\/1245\/66651757\/jvim16097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/35\/3\/1245\/66651757\/jvim16097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:07:17Z","timestamp":1770106037000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/35\/3\/1245\/8446942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.16097","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"2020-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}